Literature DB >> 29193251

Which patients with gynaecomastia require more detailed investigation?

S N Ali1, C N Jayasena1, A H Sam1.   

Abstract

Gynaecomastia may be due to medication, chronic liver or kidney disease, hypogonadism (primary or secondary to pituitary disease) or hyperthyroidism. Having excluded these aetiologies, it is imperative to be vigilant for underlying malignancy causing gynaecomastia. These include human chorionic gonadotrophin-secreting testicular and extratesticular tumours and oestrogen-secreting testicular tumours and feminising adrenal tumours.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  gynaecomastia; human chorionic gonadotrophin; malignancy; oestrogen

Mesh:

Substances:

Year:  2017        PMID: 29193251     DOI: 10.1111/cen.13526

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

Review 1.  Diagnosis and Management of Gynecomastia for Urologists.

Authors:  Lee Baumgarten; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

2.  Gynecomastia in a Transgender Boy: A Case Report.

Authors:  Raymond Fung; Mary Kathleen Greenaway; Giancarlo McEvenue
Journal:  AACE Clin Case Rep       Date:  2021-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.